PROJECT TEAM
Dr. Niels Henrik Holländer, senior oncologist at Dept. of Oncology, Zealand University Hospital. Leader of the project.
Prof. Susanne Dalton, researcher af Dept. of Oncology, Zealand University Hospital, and Danish Cancer Society. Expert on inequality in cancer.
Susanne Andresen, technician at Dept. of Clinical Biochemistry, Zealand University Hospital. Expert on quality assessment of POC equipment for decentralized use.
Keld Hundewadt, project coordinator at Dept. of Oncology, Zealand University Hospital. Responsible for funding, accounting and reporting.
THE NEED
Cancer patients are at high risk of low blood values and therefore require frequent blood tests. Combined with other treatments—such as surgery, radiotherapy, and medical therapy—this results in numerous hospital visits. The process is time-consuming, physically and mentally exhausting, and places a significant burden on both patients and their families, while also demanding considerable resources from the healthcare system.
THE SOLUTION
Use of last generation point-of-care-technology (POCT) devices for self-tests of blood values at home for patients with cancer
Blood tests at home for patients with cancer in chemotherapy treatment - Sjællands Universitets Hospital
Call 4 - 2023
1 000.000 DKK - Roche Industry Grant.
Clinical Area
Oncology
Technology
Health at home
PROJECT SUMMARY
This project addresses legal, technical, economic, and patient-related barriers to large-scale home blood testing. The goal is to enable safe monitoring for cancer patients at risk of low blood counts—reducing hospital visits and easing pressure on both patients and healthcare systems
CLINICAL IMPACT
Home-based blood self-testing reduces transportation needs, easing the burden on patients and families. In acute illness, rapid access to results enables faster treatment and may shorten hospital stays. This improves patient care while freeing healthcare resources. While mainly for lung, breast, or blood cancer patients, other groups may also benefit.